Bemnifosbuvir is currently being evaluated in the phase 3 SUNRISE-3 trial, which includes high-risk outpatients with COVID-19.
Your search for evid returned 38 results
There are currently no FDA-approved therapies targeting exon 44.
The device is implanted subcutaneously during an outpatient-compatible procedure.
The SNOO facilitates a supine position during sleep for infants up to 6 months of age who are not yet able to roll over consistently.
If approved, Opill would be the first daily oral contraceptive pill available without a prescription.
An FDA panel has voted in favor of the safety and effectiveness of Paxlovid for COVID-19.
Previously, the treatment had been approved for patients 1 year of age and older.
Several changes have been made to the adult immunization schedule 2023.
Rezafungin is an investigational echinocandin antifungal that is administered once weekly.
- Loading...
